Dalteparin Sodium – High-Stability LMWH API for Chronic Thromboembolism Treatment

  Dalteparin Sodium is a classic low-molecular-weight heparin API widely used in the prevention and treatment of chronic venous thromboembolism, tumor-associated thrombosis and dialysis anticoagulation. With the continuous growth of global chronic disease treatment demand, high-purity and high-stability Dalteparin Sodium has become a key raw material for major pharmaceutical enterprises to develop long-acting anticoagulant drugs.

  Jiulong focuses on the standardized production and export of high-quality Dalteparin Sodium. We adopt mature nitrous acid depolymerization and multi-stage purification technology to precisely control the molecular weight range and biological activity of Dalteparin Sodium. All production procedures comply with GMP and international pharmacopoeia standards, ensuring excellent batch consistency and low impurity indicators.

Dalteparin Sodium – High-Stability LMWH API for Chronic Thromboembolism Treatment

  Our Dalteparin Sodium products have stable anti-Xa activity and low endotoxin levels, with complete batch traceability and certification documents. Different from ordinary products with unstable indicators, our Dalteparin Sodium can effectively avoid clinical efficacy fluctuations and regulatory non-compliance risks, fully meeting the strict requirements of global clinical medication.

  Jiulong supports flexible order modes including laboratory sample testing and commercial bulk supply. Professional cold-chain cross-border logistics ensures long-distance transportation stability. Our technical team provides professional guidance on product application and overseas registration. If you need high-quality Dalteparin Sodium for anticoagulant drug R&D and production, contact Jiulong for customized supply solutions.